February 21, 2024

Diagnexia Partners with Aga Khan University Hospital to Enhance Pathology Services and Foster AI Diagnostic Innovations

Diagnexia, a leader in pathology expertise, is thrilled to announce a significant collaborative agreement with Aga Khan University Hospital (AKUH), Nairobi. This partnership marks a strategic step in enhancing pathology services and spearheading advancements in AI-driven diagnostics.

Under this groundbreaking agreement, Diagnexia's network of esteemed pathologists will provide expert secondary consultations to the AKUH Pathology department. This collaboration is a testament to Diagnexia's dedication to bringing subspecialty pathology expertise to regions in need, significantly improving diagnostic quality, patient care and ensuring effective treatment approaches.

Additionally, Diagnexia will contribute to the external quality assurance of cases reported by the AKUH pathology department. This initiative aligns with local department and international accreditation quality assurance requirements, ensuring the highest standards of diagnostic accuracy and patient care.

The partnership also extends into the academic realm, promoting mentorship, joint publications, and general academic advice. This synergy is expected to foster a rich environment for innovation and learning, benefiting both institutions.

Another key feature of this alliance is the development and implementation of AI tools focused on diagnostics and biomarker quantification. These state-of-the-art tools, deployed at AKUH,N aim to drive efficiencies, enhance quality, and position the hospital at the forefront of medical services.

Dr. Donal O’Shea, CEO of Diagnexia, expressed enthusiasm about the partnership, highlighting the opportunity to impact global healthcare positively.

"This collaboration is not just a business venture; it's a chance to make a real difference in patient outcomes and healthcare quality,"

said Dr. O'Shea.

Dr. Shahin Sayed, Medical Director of Laboratory Medicine and Head of Pathology at AKUH,N noted that the partnership will greatly impact patient care and upskilling of the medical experts.

“This collaboration is going to strengthen our quality control as it opens us up to external review by global peer experts,”

she said.

Professor Runjan Chetty, CMO of Diagnexia, shared his vision for the collaboration.

"We're not just providing services; we're building a bridge between international expertise and local needs in diagnostic services, teaching, research and AI innovation using a remote network of expert pathologists, which is revolutionary in the world of pathology,"

said Professor Chetty.

This partnership represents a beacon of hope for innovation and providing unique solutions to chronic problems, thereby setting a new standard in healthcare collaboration and patient care.

For more information, please contact:

info@diagnexia.com

Media contact:
Katie Higgins
Commercial Marketing Director
katie.higgins@deciphex.com
+35312210842

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
return to news

Contact Details

Invent Buidling at DCU

Ireland

Deciphex
DCU Alpha Building, Innovation Campus,
11 Old Finglas Rd, Glasnevin, Co. Dublin
D11 KXN4

Call: +353 1 582 7193

Email: Info@deciphex.com

Twitter: @deciphex

USA Headquarters Building

USA

Deciphex Inc.
1012 95th Street, Naperville,
Chicago, Illinois
60564

Call: +1 708 573 0674

Email: info@deciphex.com

USA Headquarters Building

UK

Diagnexia
Exeter Science Park Centre,
6 Babbage Way, Exeter
EX5 2FN

Call: +44 1 29730 2245

Email: Info@deciphex.com

Email Us

The details you submit will be used so that we can contact you in relation to your query either by email or your preferred method of contact. Read our privacy policy here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
Copyright Deciphex 2021
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.